Tetracycline resistance is frequent among Campylobacter jejuni isolates from Kuwait
Affiliations
Affiliations
- Department of Microbiology, Faculty of Medicine, Kuwait University, Safat, Kuwait. john@hsc.edu.kw
Abstract
Campylobacter jejuni is a major cause of diarrhea worldwide, including Kuwait. Kuwait is an important destination for commerce, employment for expatriates, and stationing of multinational troops. Knowledge about antimicrobial susceptibility of C. jejuni will be helpful for empirical treatment of infection. Tetracycline is one of the antibiotics recommended for treatment, but no data exist for tetracycline resistance in C. jejuni for the Arabian Gulf region. We characterized the tetracycline susceptibility of 85 C. jejuni isolates from diarrheal stools of patients seen at a teaching hospital in Kuwait during 2003-2006. Thirty-four (40%) isolates were tetracycline resistant (minimum inhibitory concentration >or=16 microg/ml), with 30 isolates carrying the tet(O) gene, including 19 isolates that carried the gene on a 35 kb plasmid. Four selected tetracycline-resistant donor strains transferred the plasmids and tetracycline resistances to a tetracycline-susceptible C. jejuni strain on conjugation. Tetracycline-resistant C. jejuni isolates were genetically unrelated to each other by pulsed-field gel electrophoresis. Thus, tetracycline resistance is common in C. jejuni isolates from Kuwait with the resistance determinant carried on transmissible plasmids. We conclude that tetracycline resistance is a feature of C. jejuni in Kuwait as in other parts of the world and that empirical therapy with tetracycline will yield variable results in Kuwait.
Similar articles
Gibreel A, Tracz DM, Nonaka L, Ngo TM, Connell SR, Taylor DE.Antimicrob Agents Chemother. 2004 Sep;48(9):3442-50. doi: 10.1128/AAC.48.9.3442-3450.2004.PMID: 15328109 Free PMC article.
Tetracycline resistance of Australian Campylobacter jejuni and Campylobacter coli isolates.
Pratt A, Korolik V.J Antimicrob Chemother. 2005 Apr;55(4):452-60. doi: 10.1093/jac/dki040. Epub 2005 Mar 2.PMID: 15743900
Mazi W, Senok A, Al-Mahmeed A, Arzese A, Bindayna K, Botta G.Jpn J Infect Dis. 2008 Jan;61(1):82-4.PMID: 18219143
Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland.
Wardak S, Szych J, Zasada AA, Gierczynski R.Antimicrob Agents Chemother. 2007 Mar;51(3):1123-5. doi: 10.1128/AAC.01187-06. Epub 2007 Jan 8.PMID: 17210776 Free PMC article.
Dasti JI, Groß U, Pohl S, Lugert R, Weig M, Schmidt-Ott R.J Med Microbiol. 2007 Jun;56(Pt 6):833-837. doi: 10.1099/jmm.0.47103-0.PMID: 17510271
Cited by
Albert MJ, Raghupathy R, Khan I, Azizieh FY.Sci Rep. 2019 Aug 19;9(1):12024. doi: 10.1038/s41598-019-48249-3.PMID: 31427597 Free PMC article.
Albert MJ, Haridas S, Ebenezer M, Raghupathy R, Khan I.PLoS One. 2015 Nov 5;10(11):e0142090. doi: 10.1371/journal.pone.0142090. eCollection 2015.PMID: 26540197 Free PMC article.
Albert MJ.Indian J Med Res. 2013 Jan;137(1):187-90.PMID: 23481071 Free PMC article.
Islam A, Raghupathy R, Albert MJ.Clin Vaccine Immunol. 2010 Nov;17(11):1666-71. doi: 10.1128/CVI.00255-10. Epub 2010 Sep 22.PMID: 20861330 Free PMC article.